Cabometyx 40 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FFBZ1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,258
Award facts
- Contract value 100% obligated
- $35,257.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (quantity: 30 count) on January 26, 2026. This firm fixed-price delivery order, valued at $35,257.72 with an ultimate completion date of January 27, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was made without identifying any subcontractor involvement.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. Established on November 13, 2025, with a $499.9 billion ceiling value and completion date of December 31, 2036, this prime vendor contract authorizes the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support Department of Defense military healthcare facilities worldwide. The PPV-G GEN V represents a broader $30.3 billion acquisition strategy, and DMS Pharmaceutical Group serves as one of multiple regional prime vendor contractors, positioning the company as a critical supplier for the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FFBZ1?
SPE2DR26FFBZ1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FFBZ1 worth?
The government has obligated $35,258 on SPE2DR26FFBZ1.
Is contract SPE2DR26FFBZ1 an order under another contract?
Yes. SPE2DR26FFBZ1 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBZ1 competed?
The extent of competition for SPE2DR26FFBZ1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award